台湾食品薬品監督管理局 published Guidelines for Decentralized Measures for the Implementation of Drug Clinical Trials. Below is a summary of the guidelines:
- Purpose and Concept: The document begins with an introduction that outlines the purpose and concept of decentralized measures in clinical trials.
- General Considerations: Section 2 discusses general considerations when implementing decentralized measures, including reducing face-to-face interactions, the impact on data integrity, reasons for implementation, and…
このドキュメントの詳細については、RegASK プラットフォームを参照してください。